Search for: "Andrx Corp."
Results 21 - 40
of 43
Sorted by Relevance
|
Sort by Date
19 Apr 2010, 1:34 pm
Biovail Corp., 276 F.3d 1368, 1376 (Fed. [read post]
7 Apr 2011, 11:37 am
See Schering Corp. v. [read post]
2 Nov 2023, 11:32 am
ALZA Corp. v. [read post]
18 Oct 2023, 4:58 pm
ALZA Corp. v. [read post]
15 Apr 2010, 11:19 am
See Andrx Pharms., Inc. v. [read post]
5 Aug 2010, 11:06 pm
Cybor Corp. v. [read post]
8 Dec 2010, 10:42 am
Circuit in Andrx Pharm. [read post]
10 Jan 2012, 11:58 pm
Corp. v. [read post]
30 Apr 2012, 7:54 pm
Elan Corp., 421 F.3d 1227 (11th Cir. 2005). [read post]
6 Aug 2010, 4:20 am
Sabinsa Corp. v. [read post]
28 Sep 2015, 9:07 am
Elan Corp. v. [read post]
8 Sep 2010, 5:01 pm
Andrx Corp., 369 F.3d 700, 714 (3d Cir. 2004); Buti v. [read post]
4 Sep 2010, 4:30 am
Sabinsa Corp. v. [read post]
19 Aug 2014, 8:51 pm
Andrx Pharms., Inc., 239 F.3d 1297, 1301–02 (Fed. [read post]
3 Jan 2017, 7:44 am
Andrx Corp., 369 F.3d 700 (3d Cir. 2000), held that the first level of hearsay—employees recounting customer statements evincing confusion—aren’t excludable hearsay because they aren’t submitted for their truth, but rather for their error. [read post]
6 Aug 2013, 8:36 am
Festo Corp. v. [read post]
20 Sep 2011, 2:26 pm
Biovail Corp. [read post]
4 Dec 2007, 5:55 pm
See Atari Games Corp. v. [read post]
11 Jan 2012, 2:02 pm
Andrx Pharm., LLC, 603 F.3d 935, 940 (Fed. [read post]
8 Dec 2007, 11:00 am
: (Peter Zura), Patent Tax: (Patent Prospector), (IP Spotlight), Patent litigation trends - survey results: (Patently'O), Admitting evidence of commercial success after KSR: (Delaware IP Law Blog), Abbott - A federal judge has stopped Abbott's attempt to add allegations to its claims against Johnson & Johnson subsidiary Cordis Corp in the ongoing drug eluting stent litigation: (IPLaw360), Abbott - Troll Busters Files… [read post]
